Hydroxytyrosol ameliorates stress–induced liver injury through activating autophagy via HDAC1/2 inhibition
Hydroxytyrosol (HT), a phenolic extra–virgin olive oil compound used as a food supplement, has been recognized to protect liver function and alleviate stress–induced depressive–like behaviors. However, its protective effects against stress–induced liver injury (SLI) remain unknown. Here, the anti–SLI effect of HT was evaluated in mice with chronic unpredictable mild stress–induced SLI. Network pharmacology combined with molecular docking was used to clarify the underlying mechanism of action of HT against SLI, followed by experimental verification. The results showed that accompanying with the alleviation of HT on stress–induced depressive–like behaviors, HT was confirmed to exert the protective effects against SLI, as represented by reduced serum corticosterone (CORT), aspartate aminotransferase and alanine aminotransferase activities, as well as repair of liver structure, inhibition of oxidative homeostasis collapse, and inflammation reaction in the liver. Furthermore, core genes including histone deacetylase 1 and 2 (HDAC1/2), were identified as potential targets of HT in SLI based on bioinformatic screening and simulation. Consistently, HT significantly inhibited HDAC1/2 expression to maintain mitochondrial dysfunction in an autophagy–dependent manner, which was confirmed in a CORT–induced AML–12 cell injury and SLI mice models combined with small molecule inhibitors. We provide the first evidence that HT inhibits HDAC1/2 to induce autophagy in hepatocytes for maintaining mitochondrial dysfunction, thus preventing inflammation and oxidative stress for exerting an anti‒SLI effect. This constitutes a novel therapeutic modality to synchronously prevent stress‒induced depression‒like behaviors and liver injury, supporting the advantaged therapeutic potential of HT.
危险品化学品经营许可证（带存储）